Disruption in the drug industry does not need to cease because of the “ecosystem”

  • The drug industry cannot continue to do business “as usual” and ignore the concern about drug prices.
  • Prices of many of the most popular brand-name drugs increased at nearly ten times the cost of inflation from 2012 to 2017.
  • At least 28 million Americans have experienced a spike in the cost of their prescription medications in the past 12 months.
  • 67% of drug companies increased their annual profit margins during between 2006 and 2015—with margins up to 20 percent for some companies in certain years.

Continue reading

Takeda Shire train wreck

KEY THOUGHT:  Takeda announced the sale overnight, with Shire’s board accepting Weber’s offer of £49 a share, which values the company at £46 billion. Now he’ll have to sell it to shareholders — which is not a given after Takeda saw its market cap plunge more than 20% during the talks.  Why did Takeda buy Shire?  Nothing more than a pissing match. Continue reading

Pharma should avoid Facebook at all costs

KEY TAKEAWAY: Facebook’s objective was to keep users addicted to social media as much as possible, but now that Facebook has become nothing but a media company they don’t want to play by the same rules as other media companies.  The risks of advertising on Facebook are too great while the rewards are too few. Continue reading

Developing a best in class health website

KEY TAKEAWAY: Successful marketers tend to spend less time planning and more time acting than average people. They get out into the world, try new things, make mistakes and fail at first and in doing so, they lay the foundation for future successes. Not only do they learn what will work by first finding out for themselves what does not, but they also benefit from unexpected experiences and opportunities.  To develop a great pharma product website be prepared to fail, but use a process that all but guarantees your success. Continue reading